Ryman Healthcare Limited (FRA:RH7)
Germany · Delayed Price · Currency is EUR 1.400
-0.001 (-0.07%)
Last updated: Jan 28, 2026, 3:25 PM CET
Ryman Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 759.88 | 713.8 | 650.53 | 560.11 | 503.76 | 452.41 |
Other Revenue | 47.61 | 45.37 | 37.03 | 21.5 | 5 | 3.28 |
| 807.48 | 759.16 | 687.56 | 581.61 | 508.76 | 455.69 | |
Revenue Growth (YoY) | 12.10% | 10.41% | 18.22% | 14.32% | 11.64% | 7.64% |
Cost of Revenue | 754.62 | 751.09 | 711.92 | 542.16 | 466.24 | 395.31 |
Gross Profit | 52.87 | 8.07 | -24.36 | 39.45 | 42.52 | 60.39 |
Operating Expenses | 45.33 | 48.46 | 45.99 | 37.72 | 35.7 | 32.37 |
Operating Income | 7.53 | -40.39 | -70.34 | 1.74 | 6.82 | 28.02 |
Interest Expense | -168.09 | -172.76 | -79.46 | 3.91 | -30.66 | -19.37 |
Interest & Investment Income | 0.73 | 1.53 | 2.33 | 2.14 | 0.04 | 0.1 |
Currency Exchange Gain (Loss) | - | - | - | -24.41 | - | - |
Other Non Operating Income (Expenses) | - | - | - | -197.66 | - | - |
EBT Excluding Unusual Items | -159.83 | -211.62 | -147.48 | -214.27 | -23.8 | 8.76 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -15.1 |
Asset Writedown | -273.01 | -3.77 | -135.63 | 420.47 | 745.89 | 416.85 |
Other Unusual Items | 8.2 | - | 1.18 | - | - | - |
Pretax Income | -424.64 | -215.39 | -281.93 | 206.2 | 722.08 | 410.5 |
Income Tax Expense | 139.39 | 221.44 | -112.26 | -51.64 | 29.21 | -12.56 |
Net Income | -564.03 | -436.83 | -169.67 | 257.84 | 692.87 | 423.06 |
Net Income to Common | -564.03 | -436.83 | -169.67 | 257.84 | 692.87 | 423.06 |
Net Income Growth | - | - | - | -62.79% | 63.78% | 59.82% |
Shares Outstanding (Basic) | 874 | 710 | 688 | 516 | 500 | 500 |
Shares Outstanding (Diluted) | 874 | 710 | 688 | 516 | 500 | 500 |
Shares Change (YoY) | 27.13% | 3.28% | 33.18% | 3.26% | - | - |
EPS (Basic) | -0.65 | -0.62 | -0.25 | 0.50 | 1.39 | 0.85 |
EPS (Diluted) | -0.65 | -0.62 | -0.25 | 0.50 | 1.39 | 0.85 |
EPS Growth | - | - | - | -63.96% | 63.78% | 59.82% |
Free Cash Flow | 261.73 | 254.66 | 336.44 | 219.01 | 251.68 | 156.52 |
Free Cash Flow Per Share | 0.30 | 0.36 | 0.49 | 0.42 | 0.50 | 0.31 |
Dividend Per Share | - | - | - | 0.088 | 0.224 | 0.224 |
Dividend Growth | - | - | - | -60.71% | - | -7.44% |
Gross Margin | 6.55% | 1.06% | -3.54% | 6.78% | 8.36% | 13.25% |
Operating Margin | 0.93% | -5.32% | -10.23% | 0.30% | 1.34% | 6.15% |
Profit Margin | -69.85% | -57.54% | -24.68% | 44.33% | 136.19% | 92.84% |
Free Cash Flow Margin | 32.41% | 33.55% | 48.93% | 37.66% | 49.47% | 34.35% |
EBITDA | 39.4 | -5.4 | -38.74 | 24.34 | 34.74 | 52.77 |
EBITDA Margin | 4.88% | -0.71% | -5.63% | 4.18% | 6.83% | 11.58% |
D&A For EBITDA | 31.86 | 34.99 | 31.6 | 22.6 | 27.92 | 24.76 |
EBIT | 7.53 | -40.39 | -70.34 | 1.74 | 6.82 | 28.02 |
EBIT Margin | 0.93% | -5.32% | -10.23% | 0.30% | 1.34% | 6.15% |
Effective Tax Rate | - | - | - | - | 4.04% | - |
Revenue as Reported | 808.21 | 760.7 | 689.89 | 583.75 | 1,255 | 872.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.